
Ubigene gene knockout cell lines mediated by optimized CRISPR-Cas9 technology provide reliable in vitro models for investigating gene function, signaling pathways, disease mechanisms, and therapeutic targets.
CRBN (cereblon) encodes a protein belonging to the Lon protease-related protein family. It is involved in cellular functions associated with protein and calcium channel-related processes and has been implicated in brain development. CRBN also serves as a component of the cellular machinery targeted by certain therapeutic compounds, supporting its relevance to molecular and pharmacological studies.
The HEK293 cell line is a human embryonic kidney cell line derived from adenovirus 5-transformed human embryonic kidney cells. The cells express adenovirus 5 early region 1 (E1) antigens and are permissive for adenovirus 5 host range mutants defective in E1 functions. HEK293 cells have been adapted into various derivatives, including suspension-adapted variants and engineered reporter lines for specific applications. This cell line is widely used in molecular biology, viral vector production, recombinant protein expression, gene expression studies, and research involving cellular signaling and genome engineering.
Comprehensive quality control includes STR authentication, sterility testing (bacteria and fungi), and mycoplasma screening to ensure purity and performance. Genotype is confirmed by two rounds of PCR and Sanger sequencing, and complete validation reports are provided for make-to-order products.

Cas9 cell lines in our cell bank can stably express Cas9 protein. Each Cas9 Stable Cell Line is easy to use and enables gene knockout simply by transfecting gRNA, while transfection of gRNA and donor DNA results in gene knock-in or point mutations
These Cas9 stable cell lines have been used to construct the KO cell lines for various genes, gene KO efficiency 5-10 times improved.
Selected cells, low passages, good cell condition, high activity, applicable for all kinds of gene-editing experiments.

Targeted knockout region: E2
Reference Transcript: CRBN-201
Frameshift Mutation Strategy
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use






Simply fill out the form below to leave your inquiry
— we will respond within 24 Hours
* Name
* Institution
* Products & Services of Interest
If email is not available, how else can we reach you?
How did you hear about us?